In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs.
about
Oral, ultra-long-lasting drug delivery: Application toward malaria elimination goalsPharmacokinetic aspects and in vitro-in vivo correlation potential for lipid-based formulationsQuality of medicines commonly used in the treatment of soil transmitted helminths and giardia in ethiopia: a nationwide surveyCustom fractional factorial designs to develop atorvastatin self-nanoemulsifying and nanosuspension delivery systems--enhancement of oral bioavailabilityColloid formation by drugs in simulated intestinal fluid.Case studies for practical food effect assessments across BCS/BDDCS class compounds using in silico, in vitro, and preclinical in vivo data.Development and validation of a discriminative dissolution method for atorvastatin calcium tablets using in vivo data by LC and UV methodsGemifloxacin mesylate (GFM): dissolution test based on in vivo data.Particle size reduction for improvement of oral absorption of the poorly soluble drug UG558 in rats during early development.Ex Vivo and In Vivo Characterization of Interpolymeric Blend/Nanoenabled Gastroretentive Levodopa Delivery Systems.Enhanced oral bioavailability of valsartan using a polymer-based supersaturable self-microemulsifying drug delivery system.Fabrication, characterization and in vitro evaluation of silibinin nanoparticles: an attempt to enhance its oral bioavailabilityThe use of biorelevant dissolution media to forecast the in vivo performance of a drug.Blood shizonticidal activities of phenazines and naphthoquinoidal compounds against Plasmodium falciparum in vitro and in mice malaria studies.Cyclosporine a-nanosuspension: formulation, characterization and in vivo comparison with a marketed formulation.Disintegration of solid foods in human stomach.Development and optimization of a self-microemulsifying drug delivery system for atorvastatin calcium by using D-optimal mixture design.Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs.Mathematical Models to Explore Potential Effects of Supersaturation and Precipitation on Oral Bioavailability of Poorly Soluble Drugs.In vitro release and in vitro-in vivo correlation for silybin meglumine incorporated into hollow-type mesoporous silica nanoparticles.Development of supersaturatable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs.Particle size analysis in pharmaceutics: principles, methods and applications.Predictive models for oral drug absorption: from in silico methods to integrated dynamical models.Maximising use of in vitro ADMET tools to predict in vivo bioavailability and safety.Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption.Current methods for predicting human food effect.From bench to humans: formulation development of a poorly water soluble drug to mitigate food effectInsights into cytochrome bc1 complex binding mode of antimalarial 2-hydroxy-1,4-naphthoquinones through molecular modelling.Drug delivery strategies for poorly water-soluble drugs: the industrial perspective.Biorelevant in-vitro performance testing of orally administered dosage forms.Exploration of 4(1H)-pyridones as a novel family of potent antimalarial inhibitors of the plasmodial cytochrome bc1.Experimental models for predicting drug absorption and metabolism.Availability of polymeric nanoparticles for specific enhanced and targeted drug delivery.Selecting oral bioavailability enhancing formulations during drug discovery and development.Novel inhibitors of the Plasmodium falciparum electron transport chain.Pros and cons of methods used for the prediction of oral drug absorption.Self-microemulsifying drug delivery system (SMEDDS)--challenges and road ahead.Amorphous solid dispersions: a robust platform to address bioavailability challenges.In vitro-in vivo correlations: general concepts, methodologies and regulatory applications.Evaluation of tadalafil nanosuspensions and their PEG solid dispersion matrices for enhancing its dissolution properties.
P2860
Q27901942-A42E256D-64FA-49EA-A23D-4864E02641BCQ28084784-A737F269-E9B1-4ABA-9F59-EC6F66418B74Q28542519-D60BFC21-E078-4C26-AF79-B5FB21DFE219Q30407466-EA7DE41D-F4DF-47C1-B929-963712272931Q30494603-BC23A2A0-8DF0-420B-BEEC-000E0048913EQ30576914-A5F46A9A-0C83-4245-BD00-5324CAA1D368Q30699630-57CAC8C6-AD5C-4CFE-87B7-25EDAA2ED70CQ30755146-C594DC2E-8DA9-47D6-89D7-10041EFD3BC8Q30903645-8D61A420-C643-4FA5-81A1-7E083B083A11Q33654487-365F5957-141A-4BBE-B4D1-061A13D1B800Q33674114-EC64DA55-20C5-4C1B-BF5B-BCDDFCE63108Q33713924-94F911AB-7765-43C0-9CC1-BBE38CB96998Q33954607-727E7E11-0DAC-4516-89E0-14042AAE3AB1Q34142721-149779DE-C263-4C09-82F1-1B8B688E91B3Q34409932-B3AFAC1F-65E4-4C6B-BAA5-27DCC246297DQ34788774-BDA93FE5-514D-440E-AC61-C8130AA5CADAQ35717232-F26D6D31-053A-4B13-A36B-32EEC620E86EQ35756158-DA43E295-C26F-40FE-B067-97C6CA4B5294Q35768399-0ECB1F6C-4039-4289-BE69-10DBB13741B8Q35787502-198E17AC-8F0E-44EE-BBC3-05737052DDC2Q36349701-EDDFA781-FDA8-4258-AB8E-2B854DBD3DB4Q36693368-17F75B57-334C-4175-9960-65A2DC6AB639Q36909311-3E139142-6BE6-439A-A8A2-ABE1EDA8EF2AQ36960535-696E0589-290E-4156-BF2C-AF51F67C79E3Q37058658-CCF61FD6-1E46-41F4-ADFA-3FA7EFC2CF03Q37171894-BEB4654E-635E-4669-8FAA-121A40539152Q37671854-7B927794-4493-4284-8C7D-6E3DF16C0A21Q37705739-ED9B6081-10F7-4F2E-8DD1-DB09E83527CBQ37927093-031E3611-1A54-4C34-8E2C-346180D2179EQ38017705-8E1F1B27-EDC3-4014-991D-BDDDC8174E32Q38066994-A4A589A5-4CDD-4C85-9BEE-450FA682442FQ38107970-0C2436DE-AECC-430D-88C3-8585EE6E2DFFQ38151736-C0EDF46A-004A-4A4F-8F9C-7720FCB0C7DCQ38175527-54A20F6C-6B05-461B-96FA-4D6CA75656F9Q38176703-F146DD36-4556-43E4-9867-24BB58E2DF3CQ38177366-2EE9B457-1D79-4499-AD99-215A5CF6CEEBQ38199539-91BF4F25-B6DF-4012-BA6B-EC7893D15BBCQ38358879-629E3ACF-60F1-44C8-85F8-B02B7A056261Q38541574-B59ECC6D-5221-4D2B-8D73-20B4D7E2C5FFQ38554933-16A7032E-39F6-4F2B-824C-E99D5DCE59CC
P2860
In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs.
@ast
In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs.
@en
In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs.
@nl
type
label
In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs.
@ast
In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs.
@en
In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs.
@nl
prefLabel
In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs.
@ast
In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs.
@en
In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs.
@nl
P1476
In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs.
@en
P2093
P304
P356
10.1016/S0928-0987(00)00181-0
P407
P478
11 Suppl 2
P577
2000-10-01T00:00:00Z